These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2016-002067-33||COBALT: Coversin Global Study: An Open-Label, Safety and Efficacy Trial in PNH Patients||2017-12-21||due-trials|
|Completed, report not yet due Terminated||2016-004129-18||CONSERVE: Coversin Long Term Safety and Efficacy Surveillance Study||2020-06-22||not-yet-due|
|Not reported Terminated||2017-000064-15||A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects||2019-04-17||due-trials|
|Exempt||2017-002835-40||Topical rVA576 for treatment of atopic keratoconjunctivitis: a randomised placebo double masked parallel trial (TRACKER)||not-yet-due|
|Completed, report not yet due||2017-002836-18||A Phase IIa open label single arm study of safety and efficacy of rVA576 in adult mild to moderate Bullous Pemphigoid subjects||2020-04-29||not-yet-due|
|Completed, report not yet due||2017-003847-39||CAPSTONE: Phase III Confirmatory Assessment Protocol: rVA576 Safety and Efficacy in Three-Part, Two-Arm, Randomised Open Label Evaluation in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH)||2020-09-03||not-yet-due|
|Ongoing||2020-000086-17||Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy||not-yet-due|